Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We?

J.A. Kortekaas, O. Ergonul, R.J.M. Moormann

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)

Abstract

ARBO-ZOONET is an international network financed by the European Commission's seventh framework program. The major goal of this initiative is capacity building for the control of emerging viral vector-borne zoonotic diseases, with a clear focus on West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus. To evaluate the status quo of control measures against these viruses, an ARBO-ZOONET meeting was held in Istanbul, Turkey, from 19 to 20 November 2009. The symposium consisted of three themes: (1) vaccines: new and existing ones; (2) antivirals: existing and new developments; and (3) antivector vaccines. In addition, a satellite workshop was held on epidemiology and diagnosis. The meeting brought together foremost international experts on the subjects from both within and without the ARBO-ZOONET consortium. This report highlights selected results from these presentations and major conclusions that emanated from the discussions held.
Original languageEnglish
Pages (from-to)709-718
JournalVector-Borne and Zoonotic Diseases
Volume10
Issue number7
DOIs
Publication statusPublished - 2010

Keywords

  • boophilus-microplus
  • recombinant vaccine
  • immune-responses
  • neutralizing antibodies
  • antiviral compounds
  • ribavirin therapy
  • oral ribavirin
  • saudi-arabia
  • efficacy
  • protein

Fingerprint Dive into the research topics of 'Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We?'. Together they form a unique fingerprint.

Cite this